GPT and dyspepsia: The most common AEs in the EPAG+tacrolimus group included dyspepsia (11.8%), increased creatinine (3.9%), and pruritus (3.9%); the most common AEs in the EPAG monotherapy group included dyspepsia (10.6%), elevated ALT (5.3%) and pruritus (2.6%).